Moreover, glioma cell proliferation is inhibited by cannabidiol-induced TRPV2 activation, resulting from TRPV2-dependent Ca2+ influx and increase in the uptake of cancer chemotherapeutic drug, which, in parallel, potentiates cytotoxic activity in human glioma cells [87]. This evidence concerns the gene TRPV2 and central nervous system cancer.